Forskning

September 20, 2012

Crude caffeine reduces memory impairment and amyloid β1-42 levels in an Alzheimer’s mouse model

Abstract: Alzheimer’s disease (AD), a chronic neurodegenerative disorder associated with the abnormal accumulations of amyloid b (Ab) peptide and oxidative stress in the brain, is the most common form of dementia among the elderly. Crude caffeine (CC), a major by-product of the decaffeination of coffee, has potent hydrophilic antioxidant activity and may reduce inflammatory processes. Here, we showed that CC and pure caffeine intake had beneficial effects in a mouse model of AD. Administration of CC or pure caffeine for 2 months partially prevented memory impairment in AD mice, with CC having greater effects than pure caffeine. Furthermore, consumption of CC, but not pure caffeine, reduced the Ab1–42 levels and the number of amyloid plaques in the hippocampus. Moreover, CC and caffeine protected primary neurons from Ab-induced cell death and suppressed Ab-induced caspase-3 activity. Our data indicate that CC may contain prophylactic agents against the cell death and the memory impairment in AD.